Guyer Charles Greg
Insider CIK 1811096 · BMRN EVP, Chief Technical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2026-03-17 | 2026-03-19 | 1,693 | $56.05 | $94.9K | 84,140 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2026-03-16 | 2026-03-17 | 35,680 | — | $0 | 35,680 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-03-16 | 2026-03-17 | 14,990 | — | $0 | 85,833 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2026-03-13 | 2026-03-17 | 9,109 | $58.51 | $533.0K | 70,843 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2026-03-11 | 2026-03-12 | 16,486 | $60.46 | $996.7K | 79,953 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-02-25 | 2026-02-26 | 6,176 | — | $0 | 87,393 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-02-25 | 2026-02-26 | 6,675 | — | $0 | 94,068 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-02-25 | 2026-02-26 | 2,371 | — | $0 | 96,439 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2025-03-17 | 2025-03-18 | 30,880 | — | $0 | 30,880 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-03-17 | 2025-03-18 | 13,310 | — | $0 | 80,838 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2025-03-14 | 2025-03-18 | 20,127 | $69.44 | $1.40M | 67,528 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2025-03-06 | 2025-03-07 | 7,034 | $71.28 | $501.4K | 87,655 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2025-02-28 | 2025-03-04 | 4,287 | $71.16 | $305.1K | 94,689 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-02-25 | 2025-02-27 | 9,660 | — | $0 | 89,609 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-02-25 | 2025-02-27 | 9,367 | — | $0 | 98,976 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-02-25 | 2025-02-27 | 11,040 | — | $0 | 79,949 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-11-12 | 2024-11-14 | 5,278 | $66.37 | $350.3K | 68,909 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-10-31 | 2024-11-14 | 55 | $56.01 | $3.1K | 74,187 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-05-03 | 2024-05-07 | 4,440 | $82.44 | $366.0K | 74,132 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-04-30 | 2024-05-07 | 245 | $68.65 | $16.8K | 78,572 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2024-03-15 | 2024-03-19 | 23,630 | — | $0 | 23,630 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-03-15 | 2024-03-19 | 20,424 | $83.87 | $1.71M | 78,327 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-03-15 | 2024-03-19 | 10,550 | — | $0 | 98,751 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 9,063 | — | $0 | 81,917 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 6,284 | — | $0 | 88,201 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 20,840 | — | $0 | 72,854 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-12-01 | 2023-12-05 | 11,840 | — | $0 | 52,014 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-10-31 | 2023-12-05 | 133 | $69.23 | $9.2K | 40,174 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-08-09 | 2023-08-10 | 5,360 | $93.30 | $500.1K | 40,041 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-05-04 | 2023-05-08 | 4,302 | $95.45 | $410.6K | 45,401 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-04-28 | 2023-05-08 | 239 | $66.88 | $16.0K | 49,703 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2023-03-15 | 2023-03-17 | 20,320 | — | $0 | 20,320 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-03-15 | 2023-03-17 | 8,900 | — | $0 | 51,320 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-03-15 | 2023-03-17 | 1,856 | $87.74 | $162.8K | 49,464 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-08-08 | 2022-08-10 | 6,205 | $96.56 | $599.2K | 42,168 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-05-04 | 2022-05-06 | 3,926 | $84.65 | $332.3K | 48,373 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-04-29 | 2022-05-06 | 243 | $62.41 | $15.2K | 52,299 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2022-03-15 | 2022-03-17 | 26,520 | — | $0 | 26,520 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-03-15 | 2022-03-17 | 11,040 | — | $0 | 52,976 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-03-15 | 2022-03-17 | 920 | $78.27 | $72.0K | 52,056 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-05-04 | 2021-05-05 | 3,986 | $78.35 | $312.3K | 41,695 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-04-30 | 2021-05-05 | 221 | $62.41 | $13.8K | 45,681 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2021-03-15 | 2021-03-17 | 25,650 | — | $0 | 25,650 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-03-15 | 2021-03-17 | 10,420 | — | $0 | 45,460 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2020-05-04 | 2020-05-06 | 64,150 | — | $0 | 64,150 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-05-04 | 2020-05-06 | 35,040 | — | $0 | 35,040 | SEC↗ |